Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients.

Stork, M

Retreatment with lenalidomide is an effective option in heavily pretreated refractory multiple myeloma patients. [electronic resource] - Neoplasma - 585-591 p. digital

Publication Type: Journal Article

0028-2685

10.4149/neo_2018_170519N363 doi


Antineoplastic Combined Chemotherapy Protocols
Czech Republic
Humans
Lenalidomide--therapeutic use
Multiple Myeloma--drug therapy
Retreatment
Treatment Outcome